Literature DB >> 31431032

Management of gallbladder cancer in India.

M Rajgopal Acharya1, Shraddha Patkar1, Amir Parray1, Mahesh Goel2.   

Abstract

Gallbladder cancer is a highly aggressive disease with variable prevalence across the globe. Particularly the Indo-Gangetic belt in Northern India has an incidence as high as 21/100,000. Majority of cases are detected either incidentally on pathological evaluation of cholecystectomy specimens or present with advanced disease. Radical surgery remains the mainstay of cure but only a small subset of patients is operable at presentation, and even with curative surgery recurrence rates remain high. Much debate surrounds the management of gallbladder cancer, with continuously evolving standards regarding the extent of hepatic resection and lymphadenectomy, curative resection in patients presenting with jaundice, routine excision of bile duct, and the role of neoadjuvant chemoradiotherapy. In this review we present a synopsis of currently available evidence and emerging approaches in the management of gallbladder cancer in India.

Entities:  

Keywords:  Gallbladder cancer; Tata Memorial Hospital criteria (TMH criteria); incidental gallbladder cancer; locally advanced gallbladder cancer; port site excision; revision cholecystectomy

Mesh:

Year:  2019        PMID: 31431032     DOI: 10.21037/cco.2019.07.03

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  4 in total

1.  Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L/R in gallbladder cancer.

Authors:  Ruo-Peng Liang; Xiao-Xue Zhang; Jie Zhao; Rong-Tao Zhu; Wei-Jie Wang; Qin-Wei Lu; Yu-Ling Sun
Journal:  Lab Invest       Date:  2022-09-30       Impact factor: 5.502

2.  HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.

Authors:  Yizhou Zhang; Hanrong Li; Chao Lv; Baokang Wu; Yang Yu; Chongli Zhong; Qi Lang; Zhiyun Liang; Yang Li; Yu Shi; Jian Zhang; Feng Xu; Yu Tian
Journal:  Int J Oncol       Date:  2022-08-03       Impact factor: 5.884

Review 3.  Overview of current targeted therapy in gallbladder cancer.

Authors:  Xiaoling Song; Yunping Hu; Yongsheng Li; Rong Shao; Fatao Liu; Yingbin Liu
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 4.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.